Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients

Background: Hepatocellular carcinoma [HCC] is one of the leading causes of cancer-related deaths worldwide. A major problem with HCC surveillance is the lack of reliable biomarkers. Serum transthyretin [TTR] may be a sensitive marker for the diagnosis of patients with liver cell damage, liver cirrho...

Full description

Saved in:
Bibliographic Details
Main Authors: Magda Ibrahim, Fathiya El-Raey, Naglaa Fathy, Kadrey El-Bakrey
Format: article
Language:EN
Published: Al-Azhar University, Faculty of Medicine (Damietta) 2020
Subjects:
Online Access:https://doaj.org/article/709c6afa507b4ed8be2a6b9fd04fca2e
Tags: Add Tag
No Tags, Be the first to tag this record!